(Corrects date in dateline, typographical error in spelling of wholesaler in first paragraph)
STUTTGART, Germany, March 26 (Reuters) - Celesio CLSGn.DE is bracing for more earnings decline this quarter but raised the prospect of a gain in core earnings by more than half by 2015, the German drugs wholesaler said on Thursday.
Celesio, which also operates drug retail chains including Lloydspharmacy, posted a fourth-quarter net loss of 211.2 million euros ($286.7 million), worse than expected, on write-downs on pharmacies and a decline in the pound.
Analysts polled by Reuters had expected a loss of 192 million euros on average. ($1=.7366 Euro) (Reporting by Ludwig Burger)